SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
23.06.17 | Novartis buy | Jefferies & Company Inc. | |
21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.06.17 | Novartis Hold | Deutsche Bank AG | |
21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
21.06.17 | Novartis buy | HSBC | |
20.06.17 | Roche Neutral | BNP PARIBAS | |
19.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
16.06.17 | Roche buy | Jefferies & Company Inc. | |
16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
15.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
13.06.17 | Roche overweight | Barclays Capital | |
08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
07.06.17 | Roche overweight | JP Morgan Chase & Co. | |
06.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
06.06.17 | Novartis Underweight | Morgan Stanley | |
06.06.17 | Roche buy | Deutsche Bank AG | |
06.06.17 | Roche Hold | Kepler Cheuvreux | |
06.06.17 | Roche Reduce | HSBC | |
02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
02.06.17 | Novartis Underweight | Barclays Capital | |
02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
01.06.17 | Novartis buy | Jefferies & Company Inc. | |
25.05.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
24.05.17 | Novartis Neutral | UBS AG | |
19.05.17 | Roche overweight | Barclays Capital | |
19.05.17 | Roche overweight | Barclays Capital | |
19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
19.05.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
18.05.17 | Roche overweight | JP Morgan Chase & Co. | |
17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
12.05.17 | Novartis buy | Jefferies & Company Inc. | |
12.05.17 | Roche buy | Jefferies & Company Inc. | |
12.05.17 | Novartis Underweight | Morgan Stanley | |
12.05.17 | Roche overweight | Morgan Stanley | |
11.05.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
03.05.17 | Roche overweight | JP Morgan Chase & Co. | |
28.04.17 | Roche overweight | Morgan Stanley | |
28.04.17 | Roche buy | Deutsche Bank AG |